Structure-activity relationships of neuromedin U. III. Contribution of two phenylalanine residues in dog neuromedin U-8 to the contractile activity

Chemical and Pharmaceutical Bulletin

Volumn 44, Issue 10, 1996, Pages 1880-1884

  Kurosawa, Katsuro ^a   Sakura, Naoki ^a   Hashimoto, Tadashi ^a  

^a HOKURIKU UNIVERSITY   (Japan)

Author keywords

chicken crop; neuromedin U; phenylalanine residue; smooth muscle contraction; structure activity relationship

Indexed keywords

NEUROMEDIN U; NEUROMEDIN U 8;

AMINO ACID COMPOSITION; AMINO ACID SEQUENCE; ANIMAL TISSUE; ARTICLE; AVIAN CROP; CONTROLLED STUDY; DRUG STRUCTURE; NONHUMAN; SMOOTH MUSCLE CONTRACTILITY; STRUCTURE ACTIVITY RELATION;

EID: 0029804615     PISSN: 00092363     EISSN: None     Source Type: Journal    
DOI: 10.1248/cpb.44.1880     Document Type: Article

References (25)

1. Part II: Hashimoto T., Kurosawa K., Sakura N., Chem. Pharm. Bull., 43, 1154-1157 (1995).
2. The abbreviations for amino acids and peptides are in accordance with the nomenclature of the IUPAC-IUB Joint Commission, Eur. J. Biochem., 138, 9-37 (1984), and additional abbreviations are as follows: NMU, neuromedin U; Cha, L-cyclohexylalanine; Boc, (tert-butyloxycarbonyl; DCC, N,N'-dicyclohexylcarbodiimide; HOBt, 1-hydroxybenzotriazole; BOP, benzotriazol-1-yl-oxy-tris(dimethylamino)phosphonium hexafluorophosphate; BHA benzhydrylamine; DCM, dichloromethane; DMF, N,N-dimethylformamide; MeCN, acetonitrile; AcOH, acetic acid; TEA, triethylamine; TFA, trifluoroacetic acid. Amino acids and their derivatives used in this study are of L-configuration.
3. Minamino N., Kangawa K., Matsuo H., Biochem. Biophys. Res. Commun., 130, 1078-1085 (1985).
4. Conlon J. M., Domin J., Thim L., DiMarzo V., Morris H. R., Bloom S. R., J. Neurochem., 51, 988-991 (1988).
5. Minamino N., Kangawa K., Honzawa M., Matsuo H., Biochem. Biophys. Res. Commun., 156, 355-360 (1988).
6. Domin J., Yiangou Y., Spokes R. A., Aitken A., Parmar K. B., Chrysanthou B. J., Bloom S. R., J. Biol. Chem., 264, 20881-20885 (1989).
7. Murphy R., Turner C. A., Furness J. B., Parker L., Giraud A., Peptides, 11, 613-617 (1990).
8. Kage R., O'Harte F., Thim L., Conlon J. M., Regul. Pept., 33, 191-198 (1991).
9. O'Harte F., Bockman C. S., Abel P. W., Conlon J. M., Peptides, 12, 11-15 (1991).
10. a) O'Harte F., Bockman C. S., Zeng Y., Abel P. W., Harvey S., Conlon J. M., Peptides, 12, 809-812 (1991)
11. b) Domin J., Benito-Orfila M. A., Nandha K. A., Bloom S. R., Regul. Pept., 41, 1-8 (1992).
12. Lo G., Legon S., Austin C., Wallis S., Wang Z. A., Bloom S. R., Mol. Endocrinol, 6, 1538-1544 (1992).
13. Austin C., Lo G., Nandha K. A., Meleagros L., Bloom S. R., J. Mol. Endocrinol., 14, 157-169 (1995).
14. Nandha K. A., Benito-Orfila M. A., Smith D. M., Bloom S. R., Endocrinol., 133, 482-486 (1993).
15. Nandha K. A., Bloom S. R., Biomed. Res., 14, Suppl. 3, 71-76 (1993).
16. Bockman C. S., Abel P. W., Hicks J. W., Conlon J. M., Eur. J. Pharmacol., 171, 225-257 (1989).
17. Benito-Orfila M. A., Domin J., Nandha K. A., Bloom S. R., Eur. J. Pharmacol., 193, 329-333 (1991).
18. Maggi C. A., Patacchini R., Giuliani S., Turini D., Barbanti G., Rovero P., Meli A., Br. J. Pharmacol., 99, 186-188 (1990).
19. Sakura N., Kurosawa K., Naminohira S., Sakai T., Hashimoto T., "Peptide Chemistry 1992," ed, by Yanaihara N., ESCOM Science Publishers B. V., Leiden, 1993, pp. 406-408.
20. Hashimoto T., Masui H., Uchida Y., Sakura N., Okimura K., Chem. Pharm. Bull., 39, 2319-2322 (1991).
21. Sakura N., Ohta S., Uchida Y., Kurosawa K., Okimura K., Hashimoto T., Chem. Pharm. Bull., 39, 2016-2020 (1991).
22. Okimura K., Sakura N., Ohta S., Kurosawa K., Hashimoto T., Chem. Pharm. Bull., 40, 1500-1503 (1992).
23. Sakura N., Kurosawa K., Hashimoto T., Chem. Pharm. Bull., 43, 1148-1153 (1995).
24. Castro B., Dormoy J. R., Evin G., Selve C., Tetrahedron Lett., 1975, 1219-1222.
25. Kaiser E., Colescott R. L., Bossinger C. D., Cook P. I., Anal. Biochem., 34, 595-598 (1970).